Takiguchi M, Tamura T, Goto M, Kusakawa S, Milgrom F, Kano K
Clin Exp Immunol. 1984 May;56(2):345-52.
Sera of patients with Kawasaki disease were studied for heterophile antibodies by means of enzyme immunoassay (EIA) with enzyme conjugated antisera to human IgM, IgG, IgA and IgE. Antibodies of IgM (43%), IgG (3%), IgA (11%) and IgE (49%) classes were demonstrated that combined with high molecular weight glycoprotein (HMWGP) of bovine red blood cells (BRBC) one of the antigenic preparations of the Hanganutziu-Deicher (H-D) heterophile system. Studies on sequential sera of the patients revealed that HMWGP antibodies of IgM and IgE classes began to appear in the second week, reached their peaks in the third week of the disease and declined gradually thereafter. Absorption studies on the positive sera showed that the HMWGP antibody activities were abolished by BRBC, sheep red blood cells and guinea-pig kidney tissues, confirming H-D specificity of these antibodies. EIA inhibition studies showed that the antibody activity was inhibited by HMWGP and partially by asialo-HMWGP and NGNA ganglioside rich preparation of BRBC but not by purified Paul-Bunnell or Forssman antigens. These results indicate that the H-D antibodies under investigation consist of antibodies of two different specificities; one directed against asialo-HMWGP and the other NGNA ganglioside of BRBC. Circulating immune complexes (IC) were demonstrated in 23% of the patients by means of anti-antibody inhibition test. Evidence was presented that IC in the sera of five patients were composed of H-D (HMWGP) antigen and its corresponding antibodies.
采用酶联抗人IgM、IgG、IgA和IgE血清的酶免疫分析法(EIA),研究了川崎病患者血清中的嗜异性抗体。结果显示,IgM(43%)、IgG(3%)、IgA(11%)和IgE(49%)类抗体与牛红细胞(BRBC)的高分子量糖蛋白(HMWGP)结合,HMWGP是汉格纽齐乌-戴歇尔(H-D)嗜异性系统的抗原制剂之一。对患者连续血清的研究表明,IgM和IgE类HMWGP抗体在疾病第二周开始出现,第三周达到峰值,此后逐渐下降。对阳性血清的吸收研究表明,BRBC、绵羊红细胞和豚鼠肾组织可消除HMWGP抗体活性,证实了这些抗体的H-D特异性。EIA抑制研究表明,抗体活性可被HMWGP抑制,部分被去唾液酸-HMWGP和富含NGNA神经节苷脂的BRBC制剂抑制,但不受纯化的保罗-邦内尔或福斯曼抗原抑制。这些结果表明,所研究的H-D抗体由两种不同特异性的抗体组成;一种针对去唾液酸-HMWGP,另一种针对BRBC的NGNA神经节苷脂。通过抗抗体抑制试验,在23%的患者中检测到循环免疫复合物(IC)。有证据表明,5例患者血清中的IC由H-D(HMWGP)抗原及其相应抗体组成。